These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28893776)

  • 21. Genotypic analysis of isoniazid and rifampin resistance in drug-resistant clinical Mycobacterium tuberculosis complex isolates in southern Turkey.
    Aslan G; Tezcan S; Serin MS; Emekdas G
    Jpn J Infect Dis; 2008 Jul; 61(4):255-60. PubMed ID: 18653964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disequilibrium in distribution of resistance mutations among Mycobacterium tuberculosis Beijing and non-Beijing strains isolated from patients in Germany.
    Hillemann D; Kubica T; Rüsch-Gerdes S; Niemann S
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1229-31. PubMed ID: 15728936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Whole-Transcriptome and -Genome Analysis of Extensively Drug-Resistant Mycobacterium tuberculosis Clinical Isolates Identifies Downregulation of
    de Welzen L; Eldholm V; Maharaj K; Manson AL; Earl AM; Pym AS
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in clinical Mycobacterium tuberculosis complex clinical isolates].
    Aslan G; Tezcan S; Emekdaş G
    Mikrobiyol Bul; 2009 Apr; 43(2):217-26. PubMed ID: 19621606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of reasons of the MDR M. tuberculosis strains dissemination by analysis of the rifampicin and/or isoniazid resistant isolates].
    Sivkov AIu; Boldyrev AN; Azaev MSh; Bodnev SA; Medvedeva EV; Baranova OI; Ivlev-Dantau AP; Blinova LN; Pasechnikov AD; Tat'kov SI
    Mol Gen Mikrobiol Virusol; 2006; (2):20-5. PubMed ID: 16755998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genotypic characterization of multi-drug-resistant Mycobacterium tuberculosis isolates in Myanmar.
    Aye KS; Nakajima C; Yamaguchi T; Win MM; Shwe MM; Win AA; Lwin T; Nyunt WW; Ti T; Suzuki Y
    J Infect Chemother; 2016 Mar; 22(3):174-9. PubMed ID: 26806152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rifampicin resistance in tuberculosis outbreak, London, England.
    Jenkins C
    Emerg Infect Dis; 2005 Jun; 11(6):931-4. PubMed ID: 15963290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genotyping and molecular characteristics of multidrug-resistant Mycobacterium tuberculosis isolates from China.
    Zhang Z; Lu J; Liu M; Wang Y; Qu G; Li H; Wang J; Pang Y; Liu C; Zhao Y
    J Infect; 2015 Apr; 70(4):335-45. PubMed ID: 25485999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Previous treatment in predicting drug-resistant tuberculosis in an area bordering East London, UK.
    Melzer M; Gupta N; Petersen I; Cook S; Hall B
    Int J Infect Dis; 2010 Aug; 14(8):e717-22. PubMed ID: 20542460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of mutations conferring resistance among multi- and extensively drug-resistant Mycobacterium tuberculosis isolates in China.
    Chen Y; Zhao B; Liu HC; Sun Q; Zhao XQ; Liu ZG; Wan KL; Zhao LL
    J Antibiot (Tokyo); 2016 Mar; 69(3):149-52. PubMed ID: 26486879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic polymorphism in Mycobacterium tuberculosis isolates from patients with chronic multidrug-resistant tuberculosis.
    Post FA; Willcox PA; Mathema B; Steyn LM; Shean K; Ramaswamy SV; Graviss EA; Shashkina E; Kreiswirth BN; Kaplan G
    J Infect Dis; 2004 Jul; 190(1):99-106. PubMed ID: 15195248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Minority
    Engelthaler DM; Streicher EM; Kelley EJ; Allender CJ; Wiggins K; Jimenez D; Lemmer D; Vittinghoff E; Theron G; Sirgel FA; Warren RM; Metcalfe JZ
    Am J Respir Cell Mol Biol; 2019 Dec; 61(6):789-791. PubMed ID: 31774334
    [No Abstract]   [Full Text] [Related]  

  • 33. Genetic characterisation of drug-resistant Mycobacterium tuberculosis in rural China: a population-based study.
    Hu Y; Hoffner S; Jiang W; Wang W; Xu B
    Int J Tuberc Lung Dis; 2010 Feb; 14(2):210-6. PubMed ID: 20074413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genotypic Analysis of Genes Associated with Independent Resistance and Cross-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Clinical Isolates.
    Rueda J; Realpe T; Mejia GI; Zapata E; Rozo JC; Ferro BE; Robledo J
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7805-10. PubMed ID: 26369965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Susceptibility testing breakpoints for Mycobacterium tuberculosis categorize isolates with resistance mutations in gyrA as susceptible to fluoroquinolones: implications for MDR-TB treatment and the definition of XDR-TB.
    Niward K; Ängeby K; Chryssanthou E; Paues J; Bruchfeld J; Jureen P; Giske CG; Kahlmeter G; Schön T
    J Antimicrob Chemother; 2016 Feb; 71(2):333-8. PubMed ID: 26538509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of multidrug resistance in Mycobacterium tuberculosis.
    Sekiguchi J; Miyoshi-Akiyama T; Augustynowicz-Kopeć E; Zwolska Z; Kirikae F; Toyota E; Kobayashi I; Morita K; Kudo K; Kato S; Kuratsuji T; Mori T; Kirikae T
    J Clin Microbiol; 2007 Jan; 45(1):179-92. PubMed ID: 17108078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular Investigation of Resistance to Second-Line Injectable Drugs in Multidrug-Resistant Clinical Isolates of Mycobacterium tuberculosis in France.
    Brossier F; Pham A; Bernard C; Aubry A; Jarlier V; Veziris N; Sougakoff W;
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27895017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subpopulation analysis of heteroresistance to fluoroquinolone in Mycobacterium tuberculosis isolates from Beijing, China.
    Zhang X; Zhao B; Liu L; Zhu Y; Zhao Y; Jin Q
    J Clin Microbiol; 2012 Apr; 50(4):1471-4. PubMed ID: 22259208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct detection of Mycobacterium tuberculosis and drug resistance in respiratory specimen using Abbott Realtime MTB detection and RIF/INH resistance assay.
    Tam KK; Leung KS; To SW; Siu GK; Lau TC; Shek VC; Tse CW; Wong SS; Ho PL; Yam WC
    Diagn Microbiol Infect Dis; 2017 Oct; 89(2):118-124. PubMed ID: 28780247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular and phenotypic characterisation of Mycobacterium tuberculosis resistant to anti-tuberculosis drugs.
    Imperiale BR; Zumárraga MJ; Di Giulio AB; Cataldi AA; Morcillo NS
    Int J Tuberc Lung Dis; 2013 Aug; 17(8):1088-93. PubMed ID: 23827034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.